Background: Iodine deficiency in infancy can impair neurocognitive development, but there are few available indicators of iodine intake during this critical period. In many countries, access to newborns in maternity clinics in the first few days after birth is high. If spot urine samples could be collected, reference data for urinary iodine concentration (UIC) would be useful to evaluate their iodine status. The study objectives were 1) to develop and validate a simple pad system for collection of spot urine samples for iodine; 2) to establish a reference range for UIC in newborns in the first week after birth for use in monitoring iodine nutrition. Methods: A two-stage cluster sampling was used to obtain a representative national sample of healthy, term Swiss infants, 0 to 5 days old (n ¼ 634). Gestational information, whole blood for thyrotropin, and spot urine samples on two consecutive days were collected. Results: The pad collection system was well-accepted and performed well during recovery and contamination testing. Median UIC in the total sample (n ¼ 1224) was 77 (95% confidence interval; 76, 81) mg=L; there was a gradual increase in median UIC within the range of 70-100 mg=L from days 1 through 4. Because urinary creatinine concentrations were high and variable, the UI:creatinine ratio was not useful for standardization. Conclusions: The current WHO median UIC cut-off (> 100 mg=L) for iodine sufficiency in infancy may be too high for the first week after birth. Reference data from iodine-sufficient newborns and a simple collection system may facilitate use of UIC as an indicator of iodine status in this age group.
Background
T he fetus and newborn are particularly vulnerable to iodine deficiency (ID). ID during pregnancy and infancy impairs growth and cognitive development of the offspring and is the most common preventable cause of mental retardation worldwide (1, 2) . Thus, control of ID should focus on this critical period, when fetal and newborn iodine requirements are high due to rapid turnover of thyroid hormone (3) .
The main indicator of iodine intake in populations is the median urinary iodine concentration (UIC), and World Health Organization (WHO) recommendations state a median UIC $ 100 mg=L in infants is sufficient (4) . However, the WHO also recommends an iodine intake of 90 mg=d during infancy and suggests extrapolating from this to a median UIC assuming a urine volume of 300-500 mL=d (4) , but this would produce a higher cut-off of $ 180 mg=L (5) .
For clarification, representative data on UIC in a large sample of iodine-sufficient infants would be valuable. Previous studies were limited by small numbers and, in many studies, the iodine status of the population was uncertain (6, 7) . Switzerland has a model iodized salt program; > 95% of households are using iodized salt (iodized at 20 ppm), and national urinary iodine monitoring in pregnancy as well as newborn thyrotropin (TSH) screening indicate optimal iodine nutrition (8) . Thus, Swiss newborns may be a good reference population.
Worldwide, access by health workers to newborns in the first few days after birth is generally good; in many countries most births take place in maternity clinics. Collection of spot urine samples for UIC could be used, together with newborn TSH screening when available, to help monitor iodine nutrition during this important life stage. WHO has stated the major challenge to using median UIC in this age group is the difficulties of sample collection. Therefore, the objectives of this study were 1) to develop and validate a simple method for spot urine collection in newborns; and 2) to establish a reference range for UIC in iodine-sufficient newborns in the first 4-5 days after birth.
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Subjects and Methods
A two-stage probability proportionate to size cluster sampling was used to obtain a representative national sample of Swiss newborns. Probability proportionate to size cluster sampling is the recommended method for monitoring national salt iodization programs (1) . In stage 1 of the sampling, 50 population clusters across Switzerland were recruited using stratified random selection. In stage 2, within each cluster, a maternity clinic was randomly selected. If a clinic declined participation, a replacement was selected from the same cluster. Finally, at each newborn clinic, 25 newborns were sequentially enrolled. Inclusion criteria were 1) full-term, healthy pregnancy with delivery between 38 and 42 weeks; 2) residence by the mother in Switzerland for the previous 12 months before delivery; 3) no maternal history of recent thyroid disorders; 4) no ingestion of iodinecontaining drugs or contrast media during gestation; 5) vaginal and caesarean delivery without use of iodine-containing disinfectants.
The SD of UIC in a preliminary study in Swiss newborns was used to estimate the length of the total reference range (4ÂSD); with the desired relative precision at the upper and lower limit specified as 3% of this range, the sample size was estimated to be 620 (9) . The ethical committee at the Swiss Federal Institute of Technology (ETH) Zü rich approved the study, and written informed consent was obtained from all participating mothers.
Each center completed a registration form to record consecutive births and to document inclusion and=or reason for exclusion of the mother-infant pairs. For participating subjects, individual registration forms included birth date, maternal age, gestational age, birth weight, sex, Apgar score, type of infant feeding (breast milk or formula), and history of maternal use of iodized salt and=or iodine-containing supplements during pregnancy.
The centers were told to collect two spot urine samples from each newborn on two consecutive days within 5 days after birth. Urine was collected using a pad collection method (Newcastle sterile urine collection packs, Ontex UK, Corby) developed for noninvasive, ''clean-catch'' urine sampling (10) . The nurse placed a pad inside a disposable diaper (at some centers, the pads were cut in half to improve fit inside the diaper) and checked every 10 minutes until the pad was wet with urine, but not soiled by feces. The pad was then removed, laid down on a clean counter wet side up, and using a 5 mL disposable syringe, 2 mL of urine was expressed from the pad. The urine was aliquoted into screwtop collection vials and kept refrigerated until transfer to the ETH Zü rich, where it was frozen at À258C until analysis. Whole-blood samples obtained 72-96 hours after birth were spotted and dried on filter paper (grade 903; Schleicher & Schuell, Dassel, Germany) and sent to the Protein Hormone Laboratory at the Children's Hospital of Zü rich for analysis.
Two centers contacted routinely used iodine-containing disinfectants in their delivery procedure. We enrolled a subsample of newborns (n ¼ 44) from these centers to determine the effect of the disinfectants on newborn UIC (n ¼ 88) and blood spot TSH concentrations; these data are reported separately and were not included in the reference range calculation.
To evaluate the performance of the collection pads for UIC analysis, a contamination test was done by adding Nanopure water (18 MO) (Purelab Ultra; ELGA LabWater, Wohlen, Switzerland) to the pads, waiting for 30 minutes, and then, using a 5-mL disposable syringe, expressing 2 mL of water from the pad for measurement of iodine concentration. Recovery tests were done by adding iodine solutions at concentrations of 400 mg=L and 100 mg=L and urine samples at a concentration of 133 mg=L, and then expressing 2 mL of solution or urine from the pad for measurement of iodine concentration.
Laboratory analysis
UIC was measured in duplicate at the ETH Zü rich by using a modification of the Sandell-Kolthoff reaction (11) . By this method, the CV for UIC (AE SD) in our laboratory is 10.0% at 47 AE 1 mg=L and 12.7% at 79 AE 1 mg=L. Urinary creatinine concentrations were measured at the ETH Zü rich using a modification of the Jaffe method (12) . Dried blood spots on filter paper were analyzed for TSH with the use of an immunoassay (13) . Normal reference values are < 15 mU=L blood spot.
Statistical analysis
Data processing and statistics were done with SPSS (SPSS Inc., Chicago, IL) and Excel (Microsoft, Seattle, WA). Normally distributed data were expressed as means AE SDs; nonnormally distributed data were expressed as medians (ranges). UIC and blood spot TSH concentrations were not normally distributed and were log transformed for comparisons. Means and standard deviations of the logarithm of UIC were used as parameters to fit a normal distribution, and linear percentiles were then calculated from this standard normal distribution. Stepwise linear regression analysis was done to look for predictors of UIC. P values < 0.05 were considered significant.
Results
In the evaluation of the pad collection method, iodine concentrations for all contamination test samples were below the detection limit (& 2 mg=L) of the iodine assay. In the recovery tests at iodine concentrations of 400, 130, and 100 mg=L, recovery was > 98% compared to the ''no pad'' references, with the CVs of the recovery values 4.6%, 1.9%, and 2.2%, respectively.
Data were collected between November 2005 and September 2007. Fifty-two maternity clinics were initially contacted and invited to join the study; the positive response rate was 40% (21=52). The sampling was extended to recruit clinics from three additional clusters, and the final sample included 24 participating clinics from 16 cantons in Switzerland. A total of 682 newborns were studied, the mean number of infants per clinic was 30 (range 10-44). The ratio of infants from public hospitals vs. private clinics was 263=419; the ratio from clinics in urban settings (> 100,000 inhabitants) to more rural settings was 269=413. They provided a total of 1317 urine samples collected on postnatal days 0 through 5. Of these 682 newborns, four were excluded. One mother received iodine-containing contrast material 3 weeks before delivery; the UIC in her newborn 348 DOREY AND ZIMMERMAN was > 1000 mg=L while the blood spot TSH concentration was normal. For three infants, the urine samples were misplaced or lost during transport. In the two centers where iodine-containing disinfectants were routinely used, 44 newborns were studied, with 30 delivered vaginally and 14 born by cesarean section. Samples from these newborns were analyzed separately and not included in the reference range. In these newborns, the median (range) UIC was 97 (0-1364) mg=L, and the median (range) blood spot TSH was 1.32 (0.41-11.05) mU=L. There was no significant difference in their median UIC compared to the infants born unexposed to iodine disinfectants. Although their median TSH was significantly higher than the infants unexposed to iodine disinfectants ( p < 0.05), none had an elevated blood spot TSH (> 15 mU=L). Table 1 shows the characteristics of the sample of mothers and infants who were not exposed to iodine-containing disinfectants (n ¼ 634). The sample was 47% girls and 53% boys. Ninety-one percent were delivered vaginally, and all were term infants with normal birth weights and Apgar scores. Exclusive breastfeeding was practiced by 92% of women, and only 4% of the mothers fed their babies exclusively with formula. Twelve percent of mothers acknowledged not using iodized salt, and less than 2% of mothers reported using iodine-containing supplements during pregnancy. All the newborns were euthyroid based on normal TSH values (< 15 mU=L blood spot); 0.3% (two infants) had a TSH value > 5 mU=L. Urinary creatinine concentrations were high and variable, with an overall median (range) value of 478 (1-2745) mg=L. In individual urine samples, there was no significant correlation between iodine and creatinine concentrations, or between the UIC expressed as micrograms per liter and expressed as micrograms per gram of creatinine. Table 2 and Figures 1 and 2 show the UIC data. The median UIC on day 5 samples was 119 (27-327) mg=L, but since there were only 12 samples, these are not given as separate daily values. Ninety-two percent of newborns provided two samples on two consecutive days; the mean CV of the UIC in the two samples from the same infant was 21.2%. In the total sample, the median UIC was 77 mg=L (range 0-884). There was no significant difference in median UIC comparing newborns from mothers using iodized salt to those not using iodized salt. In the regressions, sex, birth weight, gestational age, maternal age, and newborn blood spot TSH concentrations were not significant predictors of UIC. The only predictive variable was the day of urine collection (b ¼ 0.175; p < 0.0001). As shown in Fig. 2 , there was a gradual increase in UIC from days 0 through 4.
Discussion
The main challenge to measuring urine iodine in newborn infants is the difficulty of collecting urine samples from this age group. Although 24-hour solute collections are in principle more accurate than spot samples, complete collection of 24-hour urine samples in infants is notoriously difficult, with reported losses of up to 40% (14) . Even spot collections are difficult in this age group, and this may explain why several urine samples in our study had no detectable iodine concentration. Compared to later in infancy, urinary creatinine excretion during the newborn period is high and variable, and previous reports have pointed out the limitations of standardizing urinary excretion of solutes using creatinine (15) . In our sample, the median UI=creatinine ratio varied two-to threefold over days 0-4, suggesting this ratio is not useful to standardize iodine excretion in the first week of life. Thus, collection of spot samples in a sufficiently large sample of infants is likely to be the best option. In field studies, sampling large numbers of older infants in households may be difficult. In contrast, newborns in the first days of life are generally easy to study; in most countries, the majority of births take place in a maternity clinic and in many clinics, the mother and newborn are monitored for 1-4 days after birth. Thus, we chose to focus on this age group. Moreover, the simple collection protocol we used is noninvasive, easy to learn, involves no adhesive, and was well-accepted by mothers. In term infants, UIC in spot samples and 24-hour collections is modestly correlated with estimates of ingested iodine (16) . The WHO recommends the median UIC of children < 2 years old be used to assess their iodine status, and suggests a median UIC $ 100 mg=L is adequate (4). Previous reports of median UIC in children < 2 years old in iodine-sufficient countries include: Canada (n ¼ 81), 148 mg=L (6); two studies in the Netherlands (n ¼ 64, n ¼ 36), 162 and 150 mg=L, respectively (6, 14) ; and two studies in Sweden (n ¼ 39 and n ¼ 61) 112 and 96 mg=L, respectively (6, 17) . A recent study in the Czech Republic (n ¼ 181) found a median UIC of 92-109 mg=L (18) . However, interpretation of these studies is limited by their small numbers and nonrepresentative sampling.
Switzerland has a carefully monitored, long-standing national iodized salt program. Monitoring of UIC in pregnant 
DOREY AND ZIMMERMAN
women and newborn TSH indicates iodine sufficiency: in the latest national sampling of pregnant women the MUIC was 249 mg=L, and the frequency of blood spot TSH concentrations > 5 mU=L in the newborn screening program from 1999 to 2004 (n ¼ 218,665) was 1.7% (8) . Thus, Swiss newborns are a good reference population for iodine nutrition. Our nationally representative data suggest euthyroid term infants born to iodine-sufficient mothers have a median UIC in the range of 70-100 mg=L in the first 4-5 days after birth. These data need to be confirmed in other iodine-sufficient populations, but it appears the recommended WHO cut-off for infancy (100 mg=L) (4) should be revised downwards for infants in the first week after birth. It may be that older iodinesufficient infants, who have greater intakes of breast milk and=or formula, have a higher MUIC. This is suggested by our data, where the MUIC gradually increased from 60 to 100 mg=L over the first 5 days after birth, likely reflecting increasing breast milk supply. However, a previous study of older infants in central Switzerland (n ¼ 237) reported a median UIC of 62-70 mg=L (19) , similar to the median UIC in the present study. Our data have several limitations. First, they likely do not apply to premature infants and=or low birth weight infants who may have lower iodine intakes. Second, although we excluded women with a history of thyroid disorders, because we did not measure thyroid function and=or anti-thyroid antibodies, it is possible that some women with thyroid disease went unrecognized (20) . Also, maternal smoking may influence breast milk iodine concentrations (21) , and smoking was not an exclusion criteria. Breast milk intake is low in the first few days after birth (16), so that a major portion of the newborn's UIC may be derived from degradation of thyroid hormone rather than dietary iodine intake. Finally, because of marked maternal diuresis that occurs in the first few days postpartum, accurate determination of maternal iodine status from urinary iodine concentrations is problematic during this period. Thus, we did not measure UIC in the mothers. However, it is likely they were iodine sufficient based on recent national data from Swiss pregnant women showing clear iodine sufficiency (8) .
Indirectly, our data provide information on iodine intakes in the first few days after birth in mostly breastfeeding newborns in areas of iodine sufficiency. The WHO recommends an iodine intake of 90 mg=d for infancy (1) , while the Adequate Intake of the U.S. Institute of Medicine for age 0-6 months is 110 mg iodine=d (22) . Iodine intake in infancy can be estimated from the median UIC, using the assumptions that 90% of iodine intake is excreted in the urine and the average volume of urine is 300-500 mL=d (4). Extrapolations using the above recommendations suggest median UIC in iodine-sufficient infants should be $ 180-200 mg=L (5), far above our data and those from other iodine-sufficient countries (6, 14, 17, 18) . Extrapolating from our median UIC suggests the corresponding mean daily iodine intake in iodine-sufficient Swiss newborns in the first week is & 30-50 mg=d.
This estimated iodine intake is consistent with 1) data from balance studies in 1-month-old infants that suggest the mean iodine requirement is likely not more than 8-10 mg=kg=d (3,16,23); 2) the estimate of 40 mg iodine=d in the 1989 U.S. Recommended Dietary Allowance extrapolated from the relative energy requirements of adults (24) ; and 3) and breast milk iodine concentrations in Switzerland of & 60-80 mg=L (18), assuming breast milk intakes are & 350-550 mL=d at days 3-5 (25) . It is also consistent with the formula derived from the infant balance studies of Ares et al. (16) , which predicts that a median UIC of 80 mg=L corresponds to a daily iodine intake of & 35 mg=d.
Another potential indicator of iodine status in the newborn period is TSH; a high frequency of transiently elevated TSH concentrations in newborn screening for congenital hypothyroidism may reflect iodine deficiency (8) . In most industrialized countries, TSH measurements are routinely done by screening laboratories, and dependable UIC measurements are hard to come by. However, unless already in place, TSH screening is not recommended by WHO to monitor iodine status because it is relatively expensive, and assays and sample collection have not been standardized (4) . Until newborn TSH screening is more widely available, the median UIC could be a useful indicator for assessing iodine status in newborns, assessing iodine intake close to the critical stages of brain development affected by iodine deficiency. Worldwide, there are many national and regional laboratories where UIC is a routine measurement. In this context, our reference data could be used by other countries for monitoring, and, if necessary, allow early and thus more effective iodine prophylaxis during pregnancy, lactation, and infancy.
